Jeffrey Fuller

Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole

Ana Espinel‐Ingroff, Ana Isabel Aller, Laura Rosío Castañón-Olivares et al. · Antimicrobial Agents and Chemotherapy · 2012 · 247 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +14

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

Ana Espinel‐Ingroff, Maiken Cavling Arendrup, Michael A. Pfaller et al. · Antimicrobial Agents and Chemotherapy · 2013 · 208 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

HOW DEFINITION OF MENTAL HEALTH PROBLEMS CAN INFLUENCE HELP SEEKING IN RURAL AND REMOTE COMMUNITIES

Jeffrey Fuller, Jane Edwards, Nicholas Procter et al. · Australian Journal of Rural Health · 2000 · 198 citations · Full text

Medicine, Psychiatry, Behavioral Health +12

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution

Michael A. Pfaller, Ana Espinel-Ingroff, Mariana Castanheira et al. · Journal of Clinical Microbiology · 2012 · 168 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

Ana Espinel‐Ingroff, M. Cuenca‐Estrella, Annette W. Fothergill et al. · Antimicrobial Agents and Chemotherapy · 2011 · 160 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16